1 / 39

Malabsorption Group A

Malabsorption Group A. Malabsorption Syndrome. Diminished intestinal absorption of one or more dietary nutrients Not an adequate final diagnosis Most are associated with steatorrhea Increase in stool fat excretion of >6% dietary fat intake. Approach to the Patient. Malabsorption.

favian
Download Presentation

Malabsorption Group A

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MalabsorptionGroup A

  2. Malabsorption Syndrome • Diminished intestinal absorption of one or more dietary nutrients • Not an adequate final diagnosis • Most are associated with steatorrhea • Increase in stool fat excretion of >6% dietary fat intake

  3. Approach to the Patient Malabsorption

  4. History, Symptoms and Initial Preliminary Observation • Extensive small-intestinal resection for mesenteric ischemia • Short bowel syndrome • Steatorrhea with chronic alcohol intake and chronic pancreatitis • Pancreatic exocrine dysfunction

  5. Active Transport of Site-specific Dietary Nutrient Absorption • Throughout SI (Proximal>Distal) • Glucose, amino acids, lipids • Proximal SI (esp. duodenum) • Calcium • Iron • Folate • Ileum • Cobalamin • Bile acids

  6. Adaptation • Morphologic and functional • Due to segmental resection • Secondary to the presence of luminal nutrients and hormonal stimuli • Critical for survival

  7. Steatorrhea • Quantitative stool fat determination (72 hours) • Gold standard • Qualitative Sudan III stain • Does not establish degree of fat malabsorption • For preliminary screening studies • Blood, breath, and isotropic test • Do not directly measure fat absorption • Excellent sensitivity only with obvious steatorrhea • Not survived transition from research laboratory to commercial application

  8. Laboratory Testing • Vitamin D malabsorption • Evidence of metabolic bone disease • Elevated serum ALP • Reduced serum calcium • Vitamin K malabsorption • Elevated prothrombin time • Without liver disease • No intake of anti-coagulants

  9. Laboratory testing • Cobalamin/Folate malabsorption • Macrocytic anemia • Iron malabsorption • Iron deficiency anemia • No occult bleeding from GIT • Non-menstruating female • Exclusion of celiac sprue • Iron is absorbed in the proximal SI

  10. Diagnostic Procedures Malabsorption

  11. Diagnosis of Malabsorption • Effect of prolonged (>24h) fasting on stool output • Osmotic diarrhea • Decrease in stool output: Presumptive evidence that diarrhea is related to malabsorption • Secretory diarrhea • Persistence of stool output: Not due to nutrient deficiency

  12. Stool Osmotic Gap Useful in differentiating secretory from osmotic diarrhea • Normal: 290-300 mosmol/kg H20 • Significant osmotic gap • Suggests the presence of anions other than Na and K are present in the stool, presumably the cause of diarrhea • Diff >50: osmotic gap present, dietary nutrient is not absorbed • Diff <25: dietary nutrient is not responsible for the diarrhea 2 x (stool [Na+] + [stool K+]) ≤ stool osmolality

  13. Cobalamin Absorption

  14. Schilling Test • Pernicious Anemia • Atrophy of gastric parietal cells lead to absence of gastric acid and intrinsic factor secretion • Chronic Pancreatitis • Deficiency of pancreatic proteases to split the cobalamin-R binder complex • Achlorydia • Absence of another factor secreted with acid that is responsible for splitting cobalamin from the proteins in food • Bacterial Overgrowth syndromes • Bacterial utilization of cobalamin • Ileal dysfunction • Impaired cobalamin – intrinsic factor uptake

  15. Schilling Test

  16. Biopsy of Small-Intestinal Mucosa • Essential in the evaluation of a patient with documented steatorrhea or chronic diarrhea • Preferred method to obtain histologic material of proximal small-intestinal mucosa • Indications: • Evaluation of a patient either with documented or suspected steatorrhea or with chronic diarrhea • Diffuse or focal abnormalities of the small intestine defined on a small-intestinal series

  17. Biopsy Lesions and Findings

  18. Results of Diagnostic Studies in Different Causes of Steatorrhea

  19. Differential Diagnosis for Chronic Diarrhea: Approach to a Patient with Malabsorption

  20. Disease Entities Causing Malabsorption

  21. Celiac Sprue • Other names: • Nontropicalsprue, Celiac disease, gluten-sensitive enteropathy • Etiology is not known • Environmental – gliadin-associated • Immunologic – IgA antigliadin, IgA antiendomysial, IgA anti-tTg antibodies • Genetic – HLA-DQ2 allele • Protean manifestations  most of which are secondary to nutrient malabsorption

  22. Onset of symptoms occur at ages ranging from first year of life to eighth decade • Clinical manifestations: • Appear with the introduction of cereals in an infants diet • ranges from significant malabsorption to multiple nutrients, diarrhea, steatorrhea, weight loss, consequences of nutrient depletion to absence of any GI symptoms but with evidence of a single nutrient depletion • Hallmark: malabsorption and histologic changes

  23. Mechanism of diarrhea: • Steatorrhea • Secondary lactase deficiency • Bile acid malabsorption • Endogenous fluid secretion • Associated diseases: • Dermatitis herpetiformis (DH) • DM type 1 • IgA deficiency • Complications: • GI and non GI neoplasms • Intestinal ulceration • Refractory sprue • Collagenoussprue

  24. Tropical Sprue • Affects 5-10% of population in some tropical area • Etiology and pathogenesis is uncertain • Clinical manifestations: • Chronic diarrhea • Steatorrhea • Weight loss • Folate and cobalamin deficiencies

  25. Short Bowel Syndrome • General term for digestive problems that occur after a resection • Depends on • Segment resected • Length of segment • Presence of ileocecal valve • Extent of colon removal • Residual disease • Generally, need to lose 2/3 of intestine • Usually acquired • Can be congenital in children • Congenital short bowel • After resection, intestine undergoes adaptation.

  26. Short bowel syndrome Clinical Presentation Pathophysiology • Diarrhea • Steatorrhea • Possibility of hyperoxaluria • Increase in gallstone risk • Increase in gastrin levels • Removal of Ileum • Bile unabsorbed • Stimulates colonic fluid and electrolyte secretion • Removal of ileocecal valve • Bacterial overgrowth • Decrease in intestinal time • Removal of intestinal mucosa • Lactose intolerance • Lipid, fluid and electrolytes are not absorbed

  27. Short bowel syndrome Key Points • Follows resection of intestines • Generally inadequacy in absorbing food and fluids because of lack of surface area

  28. Bacterial Overgrowth Syndrome • Proliferation of colonic type bacteria within small intestine • Clinical Manifestation • Diarrhea • Steatorrhea • Macrocytic anemia

  29. Bacterial Overgrowth Syndrome Pathogenesis Etiology

  30. Bacterial Overgrowth Syndrome Key points • Macrocytic anemia • Because of lack of B12 • Stasis = allows bacteria to multiply

  31. Whipple’s Disease • Insidious in presentation • Chronic multisystem disease • Usually causes • Clinical Manifestation • Diarrhea • Steatorrhea • Weight loss • Abdominal pain • Arthralgia • CNS/ cardiac problems

  32. Whipple’s Disease Epidemiology Etiology and Pathogenesis • More common in men • Middle aged caucasian men • Fatal if left untreated • T. whipplei • Gram negative • Rod shaped • Presence of PAS (+) macrophages in SI lamina propria • Steatorrhea caused by • SI mucosal injury • Lymphatic obstruction

  33. Whipple’s Disease Key points • Rare, SYSTEMIC disease • Insidious • CNS and cardiac symptoms • Dementia = POOR prognosis • Caused by damage to mucosa and lymphatic obstruction

  34. Protein Losing Enteropathy • Group of diseases with Hypoproteinemia and edema WITHOUT • Proteinuria/ kidney problems • Protein synthesis defects/ liver problems • Clinical Manifestation • Peripheral edema • Diarrhea • Steatorrhea

  35. Protein Losing Enteropathy Pathogenesis Etiology • Excess protein loss in the GI tract • Exceeds the normal 10% protein catabolism

  36. Protein Losing Enteropathy Key points • Peripheral edema, hypoproteinemia • More than >10% total protein breakdown • Proteins lost through exudates, altered permeability, lymphatic obstruction

  37. Treatment

More Related